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EDITORIAL 
Hyperlactatemia and lactic acidemia are common metabolic disorders after cardiac surgery 
with cardiopulmonary bypass. In this issue of the Journal of Cardiothoracic and Vascular 
Anesthesia, Mittnacht et al
1
 sought to provide evidence through a retrospective data analysis 
that helps define the prognostic relationship between postoperative lactic acidosis and mitral 
valve surgery. The authors examined a clinical database from a cardiac surgery centre with a 
high volume caseload; however, being a retrospective study, bias cannot be eliminated. In 
addition, in view of the single centre status of the study the interpretation of these data has to 
be viewed in the context of other centre specific factors that would affect the results. 
However, the population analysed are sick cardiac surgical patients with a significant 
proportion with preoperative heart failure (41%), pulmonary hypertension (34%) and 
described as ASA physical status 3 and above (66%). 
 
The imbalance between demand and supply at tissue level is ultimately viewed as the 
harbinger of organ dysfunction associated with high mortality. The origin of the process may 
differ however they lead to a common end point. The problem is that the point where this 
occurs is difficult to diagnose or detect and the likelihood of this happening depends on the 
physiological reserve of the patient to compensate for the pathophysiological insult. Serum 
lactate for a long time has been used as a surrogate marker to help detect this process with 
significant evidence indicating worse outcomes in patients with sepsis and other low flow 
states.
2
 Cardiac surgery patients postoperatively can be ascribed to the latter.  Blood lactate 
levels represent a balance between production and elimination and in cardiac surgery patients 
an increase in lactate can be attributed to factors increasing production and decreasing 
clearance e.g. hypothermia, postcardiotomy heart failure, inotrope use, postoperative acute 
kidney injury, acute liver dysfunction and blood transfusions.  
 However, there is a temporal relationship between the insult and measured blood lactate 
levels as the expectation is that a combination of patient reserve, restoration of normal 
physiology and critical care support with time should translate to lactate level returning to 
normal levels. Mittnacht et al
1
 have specifically looked at analysing this specifically in 
patients having mitral valve surgery. The burden of mitral valve disease is very high with 
patients presenting with preoperative heart failure, pulmonary hypertension, right ventricular 
dysfunction and atrial fibrillation each of which independently predict mortality. It is 
expected that the pathophysiological insult of cardiopulmonary bypass is likely to be 
exacerbated in the context of mitral valve surgery hence these patients represent a target 
population to investigate. 
 
The trend in postoperative lactate levels and mortality was investigated by Mak et al 
3
 in a 
single centre retrospective matched cohort analysis of cardiac surgical patients. Each patient 
with hyperlactemia was matched with two patients with normal lactate. Their results 
illustrated a relationship between the rate of rise of lactate and mortality, with non-survivors 
presenting with higher mean peak lactate and the mean time taken to peak was considerably 
longer (lactate – 11 mmol/l vs 3 mmol/l, time to peak – 37.6hours vs 7.5 hours). There is 
some congruency in the overall message of these two studies, however Mittnacht et al within 
the context of the mitral valve population have sought to qualify more precisely the 
interpretation of hyperlactemia. It is well established that lactate on arrival in the intensive 
care unit can be predictive of poor outcomes but how good it is as a predictor is difficult to 
ascertain. The authors recognised that significant hyperlactatemia on admission to intensive 
care unit occurred at a higher level (7 mmol/l) and this was associated with higher mortality. 
However, more than half of the patients that died did not have significantly high lactate levels 
on admission. Therefore, the focus should be on the process and mechanisms causing the 
elevation of lactate. Irrespective of starting lactate, the continued rise of the lactate levels in 
the postoperative period despite support is probably indicative of the non-resolution of the 
supply demand substrate imbalance at tissue level that started whilst on cardiopulmonary 
bypass.  
 
Epinephrine (adrenaline) was the first line inotrope to aid separation from cardiopulmonary 
bypass in accordance with local protocols. Epinephrine causes increased glycolysis and 
glycogenolysis in muscle leading to lactatemia.
4 
This increase is often mild and transient 
however in the context of other factors it may contribute to significantly higher lactate levels 
seen on intensive care unit admission in the Mittnacht study. Given the retrospective nature 
of this study it is difficult to control for this confounder. Conversely, it is also possible to 
interpret the higher lactate levels on admission to be a reflection of the population studied as 
a significant proportion had mitral regurgitation as the primary pathology, heart failure and 
pulmonary hypertension. 
 
In contrast to this, other studies have shown that lactate on admission is more predictive of 
mortality.
5 
In a prospective analysis of 325 patients undergoing cardiac surgery with 
cardiopulmonary bypass, Maillet et al, sought to determine respective frequencies, risk 
factors, and outcomes of no hyperlactatemia, immediate hyperlactatemia (on admission to 
intensive care unit), or late hyperlactatemia after cardiac surgery. In this study all patients 
received normothermic cardiopulmonary bypass thus removing hypothermia as a factor in the 
etiogenesis of postoperative hyperlactatemia. Early hyperlactatemia was defined as an 
admission lactate of 3 mmol/l or more and interestingly a receiver operator characteristic 
(ROC) curve for lactate at 3 mmol/l and 5 mmol/l revealed that 3 mmol/l had the best balance 
of specificity and sensitivity. Similarly, early and late hyperlactatemia predicted higher 
morbidity and mortality however early hyperlactatemia was more predictive. Factors 
contributing to late hyperlactatemia included hyperglycemia and adrenaline use. This 
suggests a disconnect between the intraoperative factors causing high lactate and the 
postoperative factors. In other words if a patient arrives in critical care unit with a normal 
lactate the assumption is that substrate imbalance that started on cardiopulmonary bypass has 
resolved and a late rise in lactate is probably due a new acquired process. If the intra-
operative dysfunction has not resolved then the presenting lactate in the intensive care unit 
would be high and would probably continue to increase despite physiological support. 
Comparing the two studies, they have tried to identify the same population of patients whose 
outcomes are poor – patients with post-cardiopulmonary bypass low cardiac output state 
contributing to the substrate imbalance identified by hyperlactatemia. The study design by 
Maillet et al has the tendency to miss patients with an insidious clinical course who may 
present initially with normal lactate levels, which continue to increase in the postoperative 
period due to continuation of the intra/postoperative deranged physiology.    
 
There is some congruency in all the evidence available on the factors contributing to 
hyperlactatemia in the postoperative period. Prolonged cardiopulmonary bypass and cross 
clamp times, use of adrenaline, preoperative atrial fibrillation and preoperative heart failure 
are associated with early and late postoperative hyperlactatemia. The pathogenesis of 
hyperlactatemia during cardiopulmonary bypass may be due to reduced tissue extraction. The 
reduction in perfusing pressure at the start of cardiopulmonary bypass contributes to this
6
 and 
also the transition from pulsatile to non-pulsatile blood flow to the liver and kidneys (main 
organs for lactate clearance).
 7 
This effect is more pronounced with longer cardiopulmonary 
bypass and cross clamp times. When hypothermia is induced on bypass there is an increase in 
serum lactate levels which resolves during rewarming and recent evidence suggests that in 
most patients this effect does not significantly contribute to postoperative hyperlactatemia. 
8, 9 
 
Mittnacht and colleagues attempted to provide clarity on the best approach to interpretation 
of hyperlactatemia in patients undergoing mitral valve surgery. The retrospective nature of 
this study however weakens the strength of the evidence provided.  It would be interesting to 
see if a prospective trial on a similar patient population with standardized perioperative 
management would yield the same results. 
The evidence available on this subject emphasizes the prognostic value of postoperative 
hyperlactatemia. Importantly, hyperlactatemia (early or late) may be indicative of a group of 
patients who after cardiopulmonary bypass are unable to restore normal cardiac output or do 
so slowly. The consequent systemic and microcirculatory effects may increase the likelihood 
of major morbidity or mortality. Large-scale multicentre randomized controlled trials should 
test the hypothesis that lactate guided resuscitation and correction of hyperlactatemia in the 
context of high-risk cardiac surgery affects clinically important outcomes. 
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